Invesaro

Stocks Health care CNC

NYSE · Health care

Centene Corp (CNC)

Centene Corp brought in $202.9B of revenue over the twelve months to June 30, 2026, up 13.9% from a year earlier. It posted a net loss of $5.1B. Operating cash flow minus capital spending left $4.3B of free cash flow in fiscal 2025. At June 30, 2026 it held $24.2B in cash against $16.1B of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on July 28, 2026.

Free, no password. An email when CNC files with the SEC.

Price
$70.16
+1.89% on the day · October 14, 2026
52-week range $31.63 to $70.37
Market cap
$34.7B
Revenue (last 12 months)
$202.9B
+13.9% year on year
Net margin
-2.5%

Key facts about Centene Corp

Net worth
Centene Corp has a market value (market cap) of $34.7B at the latest share price, and shareholders' equity of $22.6B on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Revenue and profit
In fiscal 2025 revenue was $194.8B (+19.4% year on year), with a net loss of $6.7B. Over the 12 months to June 30, 2026: revenue $202.9B, net loss $5.1B.
Cash flow
In fiscal 2025 operations brought in $5.1B of cash; after $767M of capital spending, free cash flow was $4.3B.
Latest report
The latest periodic report (quarterly report, 10-Q) was filed with the SEC on July 28, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR
Next earnings report
Centene Corp's next report is expected around October 28, 2026. That is an estimate from its filing rhythm, not a date the company has announced.

What Centene Corp does

Centene Corp is registered with the SEC under industry code SIC 6324 (Hospital & Medical Service Plans). Its shares trade on NYSE under the ticker CNC.

Revenue and profit by year

Revenue
FY18: $60.1B $60.1B FY18FY19: $74.6B $74.6B FY19FY20: $111.1B $111.1B FY20FY21: $126B $126B FY21FY22: $144.5B $144.5B FY22FY23: $154B $154B FY23FY24: $163.1B $163.1B FY24FY25: $194.8B $194.8B FY25
Net income
FY18: $900M $900M FY18FY19: $1.3B $1.3B FY19FY20: $1.8B $1.8B FY20FY21: $1.3B $1.3B FY21FY22: $1.2B $1.2B FY22FY23: $2.7B $2.7B FY23FY24: $3.3B $3.3B FY24FY25: -$6.7B -$6.7B FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$194.8B-$7.6B-$6.7B-$13.53$4.3B
2024$163.1B$3.2B$3.3B$6.31-$490M
2023$154B$2.9B$2.7B$4.95$7.3B
2022$144.5B$1.3B$1.2B$2.07$5.3B
2021$126B$1.8B$1.3B$2.28$3.3B
2020$111.1B$3.1B$1.8B$3.12$4.6B

Earnings: every quarter and the next report date

Full financial statements: income, balance sheet and cash flow

Next report expected around October 28, 2026.

Estimated from its filing rhythm: 52 weeks after its report of October 29, 2025. Not a date the company has announced. See the report calendar · Earnings, quarter by quarter

Where CNC ranks in Health care

Revenue$194.8B
#7 of 751 in Health care · Top 1%
Revenue growth+19.4%
#195 of 532 in Health care · Top 37%
Net margin-3.4%
#237 of 544 in Health care · Top 43%
Free cash flow margin2.2%
#216 of 490 in Health care · Top 44%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Latest SEC filings

What Centene Corp has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. October 8, 2026
  2. September 16, 2026
  3. August 17, 2026
  4. July 29, 2026
  5. July 28, 2026
  6. July 28, 2026
    Quarterly report 10-Q · period to June 30, 2026Revenue rose 9.9% to $53.6B versus the same quarter last year; diluted EPS $2.19 versus -$0.51.
  7. June 22, 2026
  8. May 15, 2026
  9. April 29, 2026
  10. April 28, 2026

Recent insider filings (Forms 3, 4 and 144): 10, the latest on September 30, 2026. Insider transactions on SEC

What is CNC worth? A DCF from its reported cash flow

Insider trades

What the people running Centene Corp did with its shares, from the Form 4 filings they must send the SEC within two business days.

Insiders sold $6.9M worth of shares in the last 90 days and bought none on the open market.

Bought (open market)
$0
last 90 days
Sold
$6.9M
last 90 days
Net sold
104,103
$6.9M
DateInsiderWhatSharesPriceValueFiling
September 30, 2026 Coughlin Christopher JDirector Received as pay 583 - - Form 4
September 30, 2026 Eppinger Frederick HDirector Received as pay 864 - - Form 4
September 30, 2026 Samuels Theodore R. IIDirector Received as pay 583 - - Form 4
September 30, 2026 Tanji KennethDirector Received as pay 603 - - Form 4
September 30, 2026 Tyler Lauren MDirector Received as pay 482 - - Form 4
September 15, 2026 Pienkos Theodore JCorporate Controller & CAO Shares withheld for tax 1,092 $69.41 $75.8K Form 4
August 26, 2026 Koster ChristopherSecretary & General Counsel Sold 56,500 $66.90 $3.8M Form 4
August 18, 2026 Koster ChristopherSecretary & General Counsel Sold 47,603 $65.36 $3.1M Form 4

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns CNC

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

HolderOf classSharesFiled
Vanguard Capital Management13G, passive 7.3% 35,946,964 April 29, 2026
AQR Capital Management, LLC13G, passive with 1 related filers 6.47% 31,798,738 February 13, 2026

Latest filings below 5%: The Vanguard Group 0% (March 26, 2026); Fmr LLC 0.7% (November 5, 2025); Norges Bank 1.4% (November 4, 2025); Harris Associates L P 4.1% (August 14, 2025); Capital World Investors 4.3% (November 13, 2024).

Largest institutional holders

Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 1,003 managers reported a position.

HolderSharesValueChange on quarter
BlackRock, Inc.41,446,046$2.66B+1,623,647
Vanguard Capital Management LLC31,478,140$2.02B+244,075
Aqr Capital Management LLC28,678,701$1.84B-4,935,086
Vanguard Portfolio Management LLC22,352,704$1.43B+723,167
State Street Corp21,965,370$1.41B+319,242
Geode Capital Management, LLC13,309,729$854M+322,217
Wellington Management Group Llp13,301,215$853.8M+10,757,914
Ameriprise Financial Inc12,419,397$798.2M+2,291,199
Invesco Ltd.11,179,844$717.6M+563,673
Harris Associates L P11,124,640$714.1M-2,969,891
Morgan Stanley10,051,700$645.2M+171,464
Norges Bank7,651,758$491.2Mnew
Arrowstreet Capital, Limited Partnership7,452,257$478.4M+682,492
Assenagon Asset Management S.A.7,432,058$477.1M+3,606,783
Charles Schwab Investment Management Inc6,975,962$447.8M+78,350
Goldman Sachs Group Inc6,359,176$408.2M+785,632
Two Sigma Investments, LP6,348,038$407.5M-395,908
Victory Capital Management Inc5,884,626$377.7M+2,912,366
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC5,517,580$354.2M+608,249
D. E. Shaw & Co., Inc.5,213,422$334.6M-2,314,755

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

17 insiders reported holding 3,390,894 shares in total, about $237.9M at the last price.

HolderSharesAs of
London SarahChief Executive Officer, Director 1,188,831 March 15, 2026
Asher Andrew LynnChief Financial Officer 747,989 March 15, 2026
Eppinger Frederick HDirector 370,402 September 30, 2026
Koster ChristopherSecretary & General Counsel 248,854 August 26, 2026
Smith Susan RayeChief Operating Officer 212,237 June 15, 2026
Burdick Kenneth ADirector 197,086 June 10, 2026
Mcnally Tanya MChief People Officer 127,258 April 15, 2026
Casso KatieCorporate Controller & CAO 109,776 March 15, 2026
Dallas H JamesDirector 47,874 May 12, 2026
Blume Jessica L.Director 32,357 May 12, 2026

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about CNC

What does Centene Corp do?

Centene Corp is a company in the Health care sector, listed on NYSE as CNC. Its shares trade on NYSE under the ticker CNC.

What is Centene Corp's net worth?

Centene Corp has a market value (market cap) of $34.7B at the latest share price, and shareholders' equity of $22.6B on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.

Is Centene Corp profitable?

No. Over the twelve months to June 30, 2026 it reported a net loss of $5.1B on revenue of $202.9B.

How much revenue does Centene Corp make?

Over the twelve months to June 30, 2026 Centene Corp reported revenue of $202.9B. That is 13.9% more than a year earlier.

When did Centene Corp last report?

Its most recent periodic report is the quarterly report (10-Q) filed on July 28, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the other event from October 8, 2026.

When is Centene Corp's next earnings report?

Centene Corp's next report is expected around October 28, 2026. That is an estimate from its filing rhythm, not a date the company has announced.

Similar companies

Compare CNC with

Compare CNC with any company

Follow CNC

Get an email when Centene Corp files with the SEC: results, executive changes, material agreements and annual reports.

Free, no password. An email when CNC files with the SEC.

Where the numbers come from

Financial figures are the values Centene Corp tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.